Article Text
Statistics from Altmetric.com
THE VALUE OF PHOTODYNAMIC THERAPY
Choroidal neovascularisation associated with age related macular degeneration has been treated with photodynamic therapy (PDT) over the past few years. In many ways its efficacy has been disappointing. Moreover, it is expensive. Hopley and coworkers performed a cost utility analysis to estimate the cost effectiveness of PDT therapy involving different scenarios. This study concludes that PDT treatment is the only available treatment in some forms of neovascular age related macular degeneration. Therefore, PDT can be considered moderately cost effective for patients with reasonable visual acuity but considerably less cost effective for those with initial poor visual acuity. For an analysis of this study see the editorial by Brown and Brown. See pp 980 and 979
TREATMENT OF PTERYGIUM
Pterygium is a worldwide condition but with …
Linked Articles
- Commentary
- Editorial
- Clinical science
- Clinical science
- Clinical science
- Clinical science
- Clinical science